---
title: "CRISPR/Cas12a"
---
# CRISPR/Cas12a

`technology · nucleic-acid-detection · point-of-care-testing · trans-cleavage · isothermal-amplification · lateral-flow-assay`

Last modified 2026-06-05 · 3 papers · 9 incoming links

| | |
|---|---|
| **Type** | Nucleic acid detection technology |
| **Mechanism** | Trans-cleavage of single-stranded DNA reporters |
| **Key regulators** | [[crRNA]], [[ssdna]], [[heparin]] |
| **Integration partners** | [[rpa]], [[lamp]] |
| **Sensitivity** | 10 aM; 1×10² copies/μL |
| **Applications** | Pathogen detection, viral surveillance |
| **Papers** | 3 indexed |
| **Incoming links** | 9 entities |

---

**CRISPR/Cas12a** is a rapid nucleic acid detection technology distinguished by its trans-cleavage activity on single-stranded DNA reporters, enabling sensitive and portable molecular diagnosis in [[point-of-care-testing|point-of-care]] and resource-limited settings.¹ The platform recognizes target DNA sequences and triggers non-specific cleavage of [[ssdna|ssDNA]] substrates, generating optical signals proportional to target abundance. By engineering the [[crRNA|guide RNA]] and reporter design, trans-cleavage activity can be selectively enhanced while suppressing non-specific cis-cleavage, yielding highly sensitive and robust one-pot assay formats.¹ The technology integrates seamlessly with isothermal amplification methods including [[rpa|recombinase polymerase amplification (RPA)]] and [[lamp|loop-mediated isothermal amplification (LAMP)]], enabling equipment-free diagnostics compatible with [[lateral-flow-test|lateral flow]] readout.

---

## Mechanism

CRISPR/Cas12a operates through a dual-cleavage model in which cis-cleavage activates the nuclease domain at the PAM-adjacent site on target DNA, while trans-cleavage triggers non-specific degradation of nearby [[ssdna|ssDNA]] reporters.¹ The balance between these competing activities determines assay sensitivity and specificity. The 11bp+9ss design optimizes this balance by shortening the [[crRNA|guide RNA]] complementarity to 11 nucleotides, which destabilizes the double-stranded intermediate and suppresses cis-cleavage, while a 9-nucleotide [[ssdna|ssDNA]] region complementary to the remaining target sequence preserves robust trans-cleavage activation.¹ This approach achieves a limit of detection of 1×10² copies/μL with >100-fold sensitivity improvement, operates effectively on targets spanning a 200 bp range, and functions even under suboptimal PAM conditions.¹ Rational design of the [[ssdna|ssDNA]] reporter sequence enables discrimination of single-nucleotide polymorphisms, expanding utility for precision pathogen genotyping.

---

## Isothermal amplification integration

CRISPR/Cas12a reaches its diagnostic potential through seamless integration with isothermal amplification in unified one-pot workflows. The coupled RPA-CRISPR/Cas12a system eliminates thermal cycling by amplifying target DNA at constant temperature while simultaneously generating optical signals through trans-cleavage of reporter substrates.¹ Similarly, [[lamp|LAMP]]-CRISPR/Cas12a integration combines the portability of isothermal amplification with dramatic signal amplification, achieving >20,000-fold improvement in detection sensitivity compared to LAMP alone.³ These integrated formats enable rapid turnaround suitable for outbreak surveillance and field-deployable diagnostics.

---

## Viral surveillance and foodborne pathogen detection

CRISPR/Cas12a-based systems have emerged as powerful tools for epidemiological monitoring and food safety applications. A one-pot RT-RPA/CRISPR-Cas12a assay successfully detects four major [[hand-foot-mouth-disease|hand, foot, and mouth disease (HFMD)]] virus subtypes — EV-A71, CV-A16, CV-A6, and CV-A10 — enabling real-time tracking of viral subtype distribution in wastewater for population-level disease surveillance.² In food safety, [[lamp|LAMP]]-CRISPR/Cas12a assays targeted [[listeria-monocytogenes|Listeria monocytogenes]], a critical foodborne pathogen, achieving detection limits of 0.9 copies per reaction — corresponding to the >20,000-fold sensitivity advantage noted above — making equipment-free diagnosis feasible in resource-constrained settings.³

---

## Multiplex detection via heparin regulation

A critical innovation enabling simultaneous detection of multiple viral targets without cross-reactivity is heparin-mediated modulation of Cas12a activity. Heparin sodium selectively inhibits non-specific trans-cleavage while preserving target-dependent nuclease activation, permitting clean multiplex detection of four HFMD subtypes in a single reaction.² This breakthrough eliminates inter-reaction interference that previously limited multiplexing and enables rapid characterization of mixed viral populations during seasonal epidemics and surveillance operations.

---

## Microfluidic and lateral flow platforms

Integration of CRISPR/Cas12a with [[microfluidic-chip|microfluidic]] and [[lateral-flow-test|lateral flow]] platforms has created fully integrated point-of-care diagnostic devices. A string-powered flywheel microfluidic chip (HICAS-Chip) combines on-chip sample enrichment, purification, and elution with heparin-regulated one-pot RT-RPA/CRISPR-Cas12a detection, achieving attomolar (10 aM) sensitivity with visual readout within one hour.² Fork-shaped probes labeled with multiple fluorescent molecules further enhance detection signal in lateral flow assays, delivering the >20,000-fold sensitivity improvement while maintaining compatibility with gold nanoparticle-conjugated antibody detection systems.³ These advances position CRISPR/Cas12a as a versatile platform for equipment-free diagnostics in clinical, environmental, and food safety contexts where laboratory infrastructure is unavailable.

---

## References

1. PMID:42065492 — Sensitive and robust one-pot RPA-CRISPR/Cas12a assay with elimination of cis-cleavage
2. PMID:42083769 — String-powered microfluidic chip integrating heparin-mediated one-pot RT-RPA/CRISPR-Cas12a for multiplex detection of HFMD viruses
3. PMID:41794473 — CRISPR/Cas12a and fork-shaped probe enhance LAMP-LFT integration for equipment-free detection of Listeria monocytogenes